Substance Use Patterns and Cognitive Function in Patients with Methamphetamine Use: A Study of 131 Cases

物質使用模式對於131個甲基安非他命使用者之中的認知功能關聯影響

鄭映芝(Ying Chih Cheng)；王亮人(Liang-Jen Wang)；陳枻志(Yi-Chih Chen)；黃名琪(Ming-Chyi Huang)；林式穀(Shih-Ku Lin)；陳志根(Chih-Ken Chen)

甲基安非他命 ； 認知功能 ； 愷他命 ； 物質濫用 ； methamphetamine ； cognition ； ketamine ； substance abuse

台灣精神醫學

30卷2期（2016 / 06 / 01）

128 - 136+iv

英文

目的：物質使用模式曾被報告會影響甲基安非他命使用者的認知功能，本研究主要是要探討哪些甲基安非他命使用變量可以預測甲基安非他命濫用者的認知功能缺損。方法：本研究為一橫斷面研究，本研究記錄甲基安非他命使用者的使用變量包括首次使用甲基安非他命年齡，使用總時間，使用量及使用其他非法藥物的經驗，並且使用遺傳研究診斷問卷表, 簡短思覺失調症認知評估 (BACS) 及簡短精神症狀量表來評估個案的精神科診斷、認知功能及精神病症狀。結果：本研究共招募131 位甲基安非他命使用者，在控制年齡、性別及教育程度等因素後，較長期使用甲基安非他命以及曾經使用愷他命與較差的工作記憶 (p ＜ 0.01)、執行功能 (p ＜ 0.05) 及BACS 綜合分數 (p ＜ 0.01 與p ＜ 0.05 ) 分析有顯著的關聯性，而甲基安非他命使用的總時間與曾經使用鴉片類物質則與注意力 (p ＜ 0.05) 及處理速度 (p ＜ 0.05) 有顯著的關聯，較年輕開始使用甲基安非他命則有較差的口語記憶 (p ＜ 0.05)，甲基安非他命的使用量則與運動速度有關聯 (p ＜ 0.05)。結論：在甲基安非他命使用個案上，甲基安非他命使用的總時間與曾經使用愷他命可預測後續認知缺損。各種甲基安非他命使用變項與不同領域的認知功能相關聯的機轉值得更深入探討。

Objective: Substance use patterns are among many factors been reported to influence the result of cognitive function in patients with methamphetamine (meth) use. In this study, we intended to study what meth use parameters can predict cognitive deficits in patients with meth use. Methods: In this cross-sectional study, we recruited meth users, to collect meth use parameters-onset age, duration, dose, and experience of other illicit drugs. The psychiatric diagnoses, cognitive function, and clinical psychopathology of each patient were evaluated using the Diagnostic Interview for Genetic Study, the Brief Assessment of Cognition in Schizophrenia (BACS), and the Brief Psychiatric Rating Scale, respectively. Results: We enrolled 131 patients with meth use. After controlling for age, sex and education, we found that long duration of meth use and experience of ketamine use were significantly associated with poor performance in working memory (p ＜ 0.01), executive function (p ＜ 0.05) and composite BACS score (p ＜ 0.01 and p ＜ 0.05, respectively), duration of meth use and experience of opioid use were significantly associated with poor attention (p ＜ 0.05), and processing speed (p ＜ 0.05). We also found that earlier age of first meth use was significantly associated with poor verbal memory (p ＜ 0.05). Amount of meth consumption was also found to be significantly associated with deficit in motor speed (p ＜ 0.05). Conclusion: Duration of meth use and experience of ketamine use predicted cognitive deficits in meth users in this study. The mechanisms behind association of various meth use parameters with deficits in different domains of cognition warrant further investigation.

1. Chiang, HY,Ku, YC,Chen, CK(2013).Dental manifestations leading to diagnosis of methamphetamine-induced psychotic disorder.Taiwanese Journal of Psychiatry,27,161-164.
   連結：
2. Huang, MC,Lin, SK,Chen, CK(2014).A roller coaster from methamphetamine to ketamine.Taiwanese Journal of Psychiatry,28,217-231.
   連結：
3. American Psychiatric Association(2013).Diagnostic and Statistical Manual of Mental disorders, the Fifth Edition (DSM-5).Arlington, Virgirnia, USA:American Psychiatric Association.
4. Caligiuri, MP,Buitenhuys, C(2005).Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?.Neuropsychopharmacology,30,2125-2134.
5. Chang, L,Ernst, T,Speck, O(2002).Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.Psychiatry Res,114,65-79.
6. Chen, CK,Lin, SK,Chen, YC(2015).Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.Drug Alcohol Depend,148,158-164.
7. Chen, CK,Lin, SK,Sham, PC(2003).Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.Psychol Med,33,1407-1414.
8. Chen, WJ,Liu, SK,Chang, CJ,Lien, YJ,Chang, YH,Hwu, HG(1998).Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.Am J Psychiatry,155,1214-1220.
9. Cherner, M,Suarez, P,Casey, C(2010).Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.Drug Alcohol Depend,106,154-163.
10. Chou, YH,Huang, WS,Su, TP,Lu, RB,Wan, FJ,Fu, YK(2007).Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: a SPECT study.Eur Neuropsychopharmacol,17,46-52.
11. Driesen, NR,McCarthy, G,Bhagwagar, Z(2013).The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity.Neuropsychopharmacology,38,2613-2622.
12. Gould, TJ(2010).Addiction and cognition.Addict Sci Clin Pract,5,4-14.
13. Hart, CL,Marvin, CB,Silver, R,Smith, EE(2012).Is cognitive functioning impaired in methamphetamine users? a critical review.Neuropsychopharmacology,37,586-608.
14. Herbeck, DM,Brecht, ML(2013).Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine.J Addict Dis,32,11-25.
15. Hoffman, WF,Moore, M,Templin, R,McFarland, B,Hitzemann, RJ,Mitchell, SH(2006).Neuropsychological function and delay discounting in methamphetaminedependent individuals.Psychopharmacology,188,162-170.
16. Johanson, CE,Frey, KA,Lundahl, LH(2006).Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.Psychopharmacology,185,327-338.
17. Ke, JJ,Chen, HI,Jen, CJ(2008).Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.Toxicol Appl Pharmacol,227,239-247.
18. Keefe, RS,Goldberg, TE,Harvey, PD,Gold, JM,Poe, MP,Coughenour, L(2004).The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.Schizophr Res,68,283-297.
19. Keefe, RS,Harvey, PD,Goldberg, TE(2008).Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS).Schizophr Res,102,108-115.
20. Keefe, RS,Poe, M,Walker, TM,Kang, JW,Harvey, PD(2006).The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.Am J Psychiatry,163,426-432.
21. Kuczenski, R,Everall, IP,Crews, L,Adame, A,Grant, I,Masliah, E(2007).Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat.Exp Neurol,207,42-51.
22. Marshall, JF,Belcher, AM,Feinstein, EM,O’Dell, SJ(2007).Methamphetamine-induced neural and cognitive changes in rodents.Addiction,102(Suppl 1),61-69.
23. McKetin, R,McLaren, J,Lubman, DI,Hides, L(2006).The prevalence of psychotic symptoms among methamphetamine users.Addiction,101,1473-1478.
24. Monterosso, JR,Aron, AR,Cordova, X,Xu, J,London, ED(2005).Deficits in response inhibition associated with chronic methamphetamine abuse.Drug Alcohol Depend,79,273-277.
25. Nurnberger, JI, Jr.,Blehar, MC,Kaufmann, CA(1994).Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.Arch Gen Psychiatry,51,849-859+863-864.
26. Panenka, WJ,Procyshyn, RM,Lecomte, T(2013).Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.Drug Alcohol Depend,129,167-179.
27. Rippeth, JD,Heaton, RK,Carey, CL(2004).Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.J Int Neuropsychol Soc,10,1-14.
28. Sawamura, J,Morishita, S,Ishigooka, J(2010).Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global ImpressionSchizophrenia scale? a retrospective analysis.BMC Psychiatry,10,105.
29. Scott, JC,Woods, SP,Matt, GE(2007).Neurocognitive effects of methamphetamine: a critical review and meta-analysis.Neuropsychol Rev,17,275-297.
30. Sekine, Y,Iyo, M,Ouchi, Y(2001).Methamphetaminerelated psychiatric symptoms and reduced brain dopamine transporters studied with PET.Am J Psychiatry,158,1206-1214.
31. Simon, SL,Dacey, J,Glynn, S,Rawson, R,Ling, W(2004).The effect of relapse on cognition in abstinent methamphetamine abusers.J Subst Abuse Treat,27,59-66.
32. Simon, SL,Domier, C,Carnell, J,Brethen, P,Rawson, R,Ling, W(2000).Cognitive impairment in individuals currently using methamphetamine.Am J Addict,9,222-231.
33. Toomey, R,Lyons, MJ,Eisen, SA(2003).A twin study of the neuropsychological consequences of stimulant abuse.Arch Gen Psychiatry,60,303-310.
34. Volkow, ND,Chang, L,Wang, GJ(2001).Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.Am J Psychiatry,158,377-382.

1. Wei-Ching Huang,Hung-Yu Chan(2021)。Clinical Characteristics and Rehospitalization in Patients with Schizophrenia with or without History of Amphetamine Abuse。臺灣精神醫學，35(1)，18-25。